Rating History for Apellis Pharmaceuticals (APLS) by Roth/MKM

More Stocks Rated by Roth/MKM | Latest Ratings for APLS
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
4/2/2026 Adam Walsh Downgrade Neutral
(Buy)		 41.00
(N/A)		 40.23
(41.03)		 1.99% Details